Skip to content
stoqly

Fortune Brands Innovations

FBIN NYSE Building Products Financials FY2016–FY2025

Fortune Brands Innovations' revenue fell 3.2% to $4.5 billion in fiscal 2025. Its operating margin was 11.6%, down from 16.0% a year earlier. Free cash flow was $367 million, down 22.7%. It paid out $368 million in dividends and buybacks, 100% of free cash flow. The diluted share count fell 3.6%.

Last close · Oct 23, 2026

$42.98

1.8%
Value it Compare
Revenue Total sales reported in the income statement.
$4.5B
3.2% vs prior year
Operating margin Operating income as a share of revenue.
11.6%
4.5 pts
Net income Profit after all expenses, interest and tax.
$299M
36.7%
Free cash flow Cash from operations minus capital spending.
$367M
22.7%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
7.7%
4.0 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$5.1B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
34.7x
On $1.24 EPS (TTM)

About these figures. Fortune Brands had no current portion of long-term debt and no short-term borrowings at the end of 2020, only long-term debt (checked against its balance sheet).

What Fortune Brands Innovations does

No business description yet.

Legal name
Fortune Brands Innovations, Inc.
Fiscal year ends
December 27, 2025
Latest annual report
—
Accession · CIK
0001193125-26-063960
0001519751

Revenue and margins

Fortune Brands Innovations had $4.5B of revenue in fiscal 2025, down 3.2% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

From fiscal 2016 to 2025, diluted EPS grew −0.7% a year. Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $367M in fiscal 2025, 8.2% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Fortune Brands Innovations returned $368M to shareholders in fiscal 2025, 100% of free cash flow. The diluted share count fell 3.6%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Fortune Brands Innovations yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of −$2.3B and divides by 121.2M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 34.7x · peers 17.9x · sector 26.0x.

Balance sheet

Cash, debt and the ratios that show how comfortably Fortune Brands Innovations can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $426M$643M$366M$381M$264M
Debt incl. finance leases $3.1B$3.3B$2.7B$3.2B$2.5B
Net debt / EBITDA 2.7x2.8x2.9x3.0x3.2x
Debt / equity 1.0x1.6x1.2x1.3x1.1x
Interest coverage 9.6x6.5x5.3x6.1x4.5x
Current ratio 1.4x1.6x1.7x1.3x1.8x
Quick ratio 0.9x0.9x0.9x0.7x0.9x
Total assets $5.4B$6.1B$6.6B$6.6B$6.5B
Total liabilities $4.9B$4.0B$4.3B$4.1B$4.1B
Shareholders' equity $3.1B$2.1B$2.3B$2.4B$2.4B
Net debt (− = net cash) $2.7B$2.6B$2.3B$2.8B$2.3B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$30.7M

2 insiders

Sold, 12 months

$0.0M

1 insider

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Aug 7, 2026 Jesse G SinghChief Executive Officer, Director Bought 19,560 $50.93 $1.0M Form 4
Aug 7, 2026 Matthew Edward NovakEVP, Chief Supply Chain Sold 600 $51.13 $0.0M Form 4
Aug 6, 2026 Jesse G SinghChief Executive Officer, Director Bought 19,725 $51.67 $1.0M Form 4
Jun 10, 2026 Edward P GardenDirector Bought 320,067 $40.60 $13.0M Form 4
May 20, 2026 Edward P GardenDirector Bought 5,900 $33.28 $0.2M Form 4
May 20, 2026 Edward P GardenDirector Bought 57,400 $34.89 $2.0M Form 4
May 19, 2026 Edward P GardenDirector Bought 403,000 $33.40 $13.5M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✕ ✓ ✕
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✓ ✕ ✓
Current ratio rose ✓ ✕ ✓
Share count didn't rise ✓ ✓ ✓
Gross margin rose ✓ ✓ ✕
Revenue rose relative to assets ✕ ✕ ✕
F-score 7 / 96 / 96 / 9
Accruals ratio −10.3%−3.0%−2.8%
Altman Z'' 3.333.243.61

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Fortune Brands Innovations FBIN $5.1B −3.2% 11.6% 8.2% 7.7% 34.7x 6
Allegion ALLE $15.2B 7.8% 21.1% 16.9% 21.5% 22.3x 8 Compare →
Lennox International LII $13.2B −2.7% 20.1% 12.3% 40.1% 16.7x 5 Compare →
A. O. Smith AOS $8.5B 0.3% 19.0% 14.3% 30.7% 17.1x 7 Compare →
UFP Industries UFPI $4.4B −5.0% 5.8% 4.4% 11.8% 18.6x 5 Compare →

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $5.0B $5.3B $5.5B $5.8B $3.6B $4.8B $4.7B $4.6B $4.6B $4.5B
Gross profit $1.8B $1.9B $2.0B $2.1B $2.2B $2.0B $1.9B $1.9B $2.1B $2.0B
Research and development $53.1M $50.7M $50.3M $48.2M — — — — — —
Operating income $619M $683M $595M $699M $568M $811M $774M $615M $738M $516M
Interest expense $49.1M $49.4M $74.5M $94.2M $83.8M $84.3M $119M $117M $121M $115M
Pretax income $582M $635M $537M $575M $499M $726M $667M $518M $606M $405M
Income tax $170M $160M $147M $144M $111M $167M $127M $112M $134M $106M
Net income $413M $473M $390M $432M $553M $772M $687M $405M $472M $299M
Diluted EPS $2.62 $3.03 $2.66 $3.06 $3.94 $5.54 $5.23 $3.17 $3.75 $2.47
Diluted shares 0.16B 0.16B 0.15B 0.14B 0.14B 0.14B 0.13B 0.13B 0.13B 0.12B
Cash flow
Cash from operations $651M $600M $604M $637M $826M $689M $566M $1.1B $668M $479M
Capital expenditure $149M $165M $150M $132M $151M $214M $246M $257M $193M $112M
Free cash flow $501M $435M $454M $505M $675M $475M $320M $799M $475M $367M
Depreciation and amortization $123M $130M $150M $153M $146M $171M $175M $169M $194M $194M
Stock-based compensation $32.0M $43.0M $36.1M $30.5M $47.6M $50.2M $50.2M $34.2M $39.3M $20.8M
Acquisitions $240M $125M $466M $0.0M $715M $5.2M $218M $784M $135M $0.0M
Share buybacks $425M $215M $695M $100M $188M $448M $580M $150M $240M $248M
Dividends paid $98.2M $110M $115M $123M $133M $143M $146M $117M $120M $121M
Dividends and buybacks $523M $325M $810M $223M $321M $591M $726M $267M $360M $368M
Balance sheet
Cash and short-term investments $252M $323M $263M $388M $419M $426M $643M $366M $381M $264M
Total debt $1.4B $1.5B $2.9B $2.6B $2.6B $3.1B $3.3B $2.7B $3.2B $2.5B
Finance lease liabilities $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M $0.0M
Current assets $1.4B $1.6B $1.7B $1.9B $2.2B $2.7B $2.5B $2.0B $2.0B $2.0B
Current liabilities $843M $907M $1.5B $1.4B $1.3B $2.0B $1.5B $1.2B $1.6B $1.1B
Inventory $531M $581M $679M $719M $867M $890M $1.0B $982M $960M $1.0B
Property and equipment, net $663M $740M $813M $824M $917M $671M $784M $975M $999M $806M
Total assets $5.1B $5.5B $6.0B $6.3B $7.4B $5.4B $6.1B $6.6B $6.6B $6.5B
Total liabilities $2.8B $2.9B $3.8B $3.9B $4.6B $4.9B $4.0B $4.3B $4.1B $4.1B
Shareholders' equity $2.4B $2.6B $2.2B $2.4B $2.8B $3.1B $2.1B $2.3B $2.4B $2.4B
Margins
Gross margin 36.2% 36.4% 35.7% 35.6% 59.8% 40.8% 40.9% 41.3% 44.8% 44.6%
Operating margin 12.4% 12.9% 10.9% 12.1% 15.7% 16.9% 16.4% 13.3% 16.0% 11.6%
EBITDA margin 14.9% 15.4% 13.6% 14.8% 19.7% 20.5% 20.1% 16.9% 20.2% 15.9%
Net margin 8.3% 9.0% 7.1% 7.5% 15.3% 16.1% 14.5% 8.7% 10.2% 6.7%
FCF margin 10.1% 8.2% 8.3% 8.8% 18.7% 9.9% 6.8% 17.3% 10.3% 8.2%
Returns
Return on capital 12.7% 14.0% 10.1% 11.1% 9.3% 11.7% 12.0% 10.3% 11.7% 7.7%
Return on capital employed 14.7% 15.4% 13.1% 14.9% 10.4% 17.1% 19.2% 12.4% 14.3% 9.9%
Return on equity 17.2% 19.1% 16.3% 18.8% 21.3% 26.5% 26.7% 18.5% 20.0% 12.4%
Return on assets 8.3% 8.9% 6.8% 7.1% 8.1% 12.1% 11.9% 6.4% 7.2% 4.6%
Growth
Revenue growth 8.9% 6.0% 3.8% 5.1% −37.2% 32.6% −1.6% −2.1% −0.4% −3.2%
Net income growth 31.2% 14.4% −17.6% 10.9% 28.1% 39.7% −11.1% −41.1% 16.7% −36.7%
EPS growth 35.8% 15.7% −12.2% 15.0% 28.8% 40.6% −5.6% −39.4% 18.3% −34.1%
FCF growth 66.7% −13.2% 4.3% 11.4% 33.6% −29.7% −32.5% 149.6% −40.6% −22.7%
Share count change −3.2% −1.3% −6.0% −3.5% −0.8% −0.5% −5.9% −2.7% −1.6% −3.6%
Financial health
Net debt / EBITDA 1.6x 1.5x 3.5x 2.6x 3.0x 2.7x 2.8x 2.9x 3.0x 3.2x
Debt / equity 0.6x 0.6x 1.3x 1.1x 0.9x 1.0x 1.6x 1.2x 1.3x 1.1x
Interest coverage 12.6x 13.8x 8.0x 7.4x 6.8x 9.6x 6.5x 5.3x 6.1x 4.5x
Current ratio 1.7x 1.8x 1.1x 1.4x 1.6x 1.4x 1.6x 1.7x 1.3x 1.8x
Quick ratio 1.1x 1.1x 0.7x 0.8x 1.0x 0.9x 0.9x 0.9x 0.7x 0.9x
Capital allocation
Capex / revenue 3.0% 3.1% 2.7% 2.3% 4.2% 4.5% 5.2% 5.5% 4.2% 2.5%
Stock comp / revenue 0.6% 0.8% 0.7% 0.5% 1.3% 1.1% 1.1% 0.7% 0.9% 0.5%
Payouts / FCF 104.3% 74.7% 178.4% 44.1% 47.5% 124.5% 226.6% 33.4% 75.9% 100.4%
Quality scores
Piotroski F-score 6.0 9.0 4.0 7.0 8.0 5.0 7.0 7.0 6.0 6.0
Altman Z'' 3.0 3.3 2.3 2.8 2.9 4.3 3.6 3.3 3.2 3.6
Accruals ratio −4.7% −2.4% −3.7% −3.4% −4.0% 1.3% 2.1% −10.3% −3.0% −2.8%

Source: SEC EDGAR XBRL filings (CIK 0001519751). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open